BKM120 and BYL719 (PI3K inhibitors) sensitize estrogen receptor positive breast cancer cells to tamoxifen

臺大醫院;臺大醫院-腫瘤醫學部;臺大醫學院-臨床醫學研究所;Chen, I-ChunI-ChunChenGao, MingMingGaoHsiao, Lii-PingLii-PingHsiaoHuang, Yi-WenYi-WenHuangYu, Huei-ChiehHuei-ChiehYuYeh, Ling-ChiunLing-ChiunYehCheng, Ann-LiiAnn-LiiChengLu, Yen-ShenYen-ShenLu2017-06-222018-07-062017-06-222018-07-062015http://ntur.lib.ntu.edu.tw//handle/246246/279895[SDGs]SDG3BKM120 and BYL719 (PI3K inhibitors) sensitize estrogen receptor positive breast cancer cells to tamoxifen10.1158/1538-7445.AM2015-2670